Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEFLUX: Parnaparin in Superficial Vein Thrombosis
NCT00362947Phase 3Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Aug 2006
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of parnaparin in superficial vein thrombosis (SVT), sponsored by Sant'Orsola-Malpighi University Hospital. Started Aug 2006; status: completed.
02
Drugs
parnaparin
03
Conditions
superficial vein thrombosis (SVT)
Beyond the preview
Go deeper on NCT00362947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00362947.